Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (7) , 610-613
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapyAnnals of Hematology, 2017
- Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: First Moroccan experienceLa Presse Médicale, 2017
- Nemaline myopathy and heart failure: role of ivabradine; a case reportBMC Cardiovascular Disorders, 2015
- Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasoneMuscle & Nerve, 2014
- Sporadic late-onset nemaline myopathy with MGUSNeurology, 2014
- Sporadic late onset nemaline myopathy and immunoglobulin deposition diseaseMuscle & Nerve, 2013
- Maximizing Functional Independence in Sporadic Late Onset Nemaline MyopathyPM&R, 2012
- Adult nemaline myopathy with trabecular muscle fibersMuscle & Nerve, 2009
- A “nema” of hope in the treatment of late-onset nemaline myopathyNeurology, 2008
- Sporadic late onset nemaline myopathyNeurology, 2005